Finnish invention, Planmed Verity®, wins a jackpot at the 2012 Medical Design Excellence Awards
The Planmed Verity® Extremity Scanner wins the sought-after title: the 2012 Medical Design Excellence Award (MDEA) Gold Winner, and is also nominated “Best in Show”. MDEA is the premier awards competition for the medical technology community.
The winning products were announced at the MDEA Presentation Ceremony held on Wednesday, May 23, 2012 in Philadelphia. Planmed Verity® Extremity Scanner is the Gold Winner of the Radiological and Electromechanical Devices category and was also selected “Best in Show” from all gold-winning products.
Planmed Verity® is designed to find subtle extremity fractures at the first visit to the clinic – fractures that have been the most commonly missed when using only 2D radiographs. Planmed Verity Extremity Scanner is a unique solution to the problem with fast 3D imaging at the point of care. It is intended for pre- and postoperative imaging offering better resolution, patient adaptability, and a significantly lower dose than full-body CTs. Unlike any other 3D imaging device, Planmed Verity also allows weight-bearing imaging of the extremities.
The adjustable user interfaces and efficient all-in-one workflow are also designed to maximize the operator’s soothing presence for the patient. Mobility brings additional value when positioning the system in the hospital or within the examination room.
“We are particularly proud of this award. MDEA is highly recognized and appreciated within the medical device and imaging industry”, states Mr Vesa Mattila, Vice President with Planmed Oy.
“The compact, ergonomic and mobile Planmed Verity Extremity Scanner gorgeously combines modern and elegant design into a state-of-the art functional medical imaging system.”
The judging of the MDEA competition is conducted by an impartial, independent multidisciplinary panel of jurors. Entries are evaluated on the basis of their design and engineering features, including innovative use of materials, user-related functions that improve healthcare delivery and change traditional medical attitudes or practices, features that provide enhanced benefits to the patient, and the ability of the product development team to overcome design and engineering challenges so that the product meets its clinical objectives.
Planmed Verity has a CE mark and is available for sale in the EU and many other countries where the CE certificate permits sales. FDA approval is pending.
For further information, please contact:
Mr Vesa Mattila, Vice President, Planmed Oy
Tel. +358 20 7795 301
vesa.mattila@planmed.com
Mr Chris Oldham, Director of Sales, Planmed, Inc.
Tel. (630) 235 4389
chris.oldham@planmedusa.com
Medical Design Excellence Awards
Established in 1998, the Medical Design Excellence Awards (MDEA) is the medical device industry’s premier design awards competition and the only awards program that exclusively recognizes contributions and advances in the design of medical products. The MDEA competition is open worldwide to companies and individuals involved in the design, engineering, manufacture, or distribution of finished medical devices or medical packaging.
www.MDEAwards.com
Planmed Oy and the Planmeca Group
Planmed Oy develops, manufactures, and markets advanced imaging equipment and accessories for mammography and orthopedic imaging. Planmed's extensive mammography product range covers digital and analog units, stereotactic biopsy devices, and breast positioning systems for an early detection of breast cancer. Within orthopedic 3D imaging Planmed offers low dose extremity CT imaging for quicker, easier and more accurate diagnosis at the point-of-care.
Planmed Oy exports more than 98% of its production to over 70 countries worldwide. The principal markets are Europe, Asia as well as North andLatin Americawhere the company has considerable market shares. Planmed Oy is part of the Finland-based Planmeca Group which manufactures and markets advanced equipment for medical and dental fields. The Group employs approximately 2,400 professionals and the estimated turnover for the year 2012 is MEUR 750.
www.planmed.com
Tags: